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Abstract 
Contexts: An evidence base for CAM consumption within general populations is 
emerging. However, research data on CAM use for headache disorders remains 
poorly documented. This paper, constituting the first critical review of literature on 
this topic, provides a synopsis and evaluation of the research findings on CAM use 
amongst patients with headache and migraine. 
Methods: A comprehensive search of literature from 2000 to 2011 in CINAHL, 
MEDLINE, AMED, and Health Sources was conducted. The search was confined to 
peer-reviewed articles published in English reporting empirical research findings of 
CAM use among people with primary headache or migraine.   
Results: The review highlights a substantial level of CAM use among people with 
headache and migraine. There is also evidence of many headache and migraine 
sufferers using CAM concurrent to their conventional medicine use. Overall, the 
existing studies have been methodologically weak and there is a need for further 
rigorous research employing mixed method designs and utilizing large national 
samples.  
Discussion: The critical review highlights the substantial prevalence of CAM use 
amongst people with headache and migraine as a significant health care delivery 
issue and healthcare professionals should be prepared to enquire and discuss 
possible CAM use with their patients during consultations. Healthcare providers 
should also pay attention to the possible adverse effects of CAM or interactions 
between CAM and conventional medical treatments amongst headache and migraine 
patients. 
 
Keywords 
Headache, migraine, complementary and alternative medicine, prevalence, review 
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Complementary and Alternative Medicine use for 
Headache and Migraine: A Critical Review of the 
Literature 
 
The use of complementary and alternative medicine (CAM) – a diverse group of 
healthcare practices and products not traditionally associated with the medical 
profession or medical curriculum1 – has increasingly become a mainstream 
healthcare activity in Western societies.2-6 In recent years, CAM has become an issue 
of growing importance for healthcare practitioners as well as policy-makers.1 7 8 
 
Over recent decades, the evidence base for CAM consumption within general 
populations has emerged.9-13 However, research data on CAM use for specific health 
or clinical conditions remains less well documented and the use of CAM specifically 
for headache and migraine is no exception. This paper provides the first critical, 
systematic examination of the evidence-base of this crucial healthcare issue, 
synthesizing empirical research findings and highlighting a number of gaps and 
challenges facing future research in this increasingly important practice area. 
 
 
Headache and Migraine: The Significance of Exploring CAM Use 
Headache and migraine is a very common health condition and according to the 
International Headache Society the percentage of the global adult population with an 
active general headache disorder is 46% with 11% suffering from migraines, 42% 
suffering tension-type headaches and 3% suffering chronic daily headache.14 A 
systematic review has identified the global prevalence of chronic migraine at 0–5.1%, 
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with estimates typically in the range of 1.4–2.2% of the general population.15  The 
impact of headache disorders is substantial and the World Health Organization ranks 
headache disorders as some of the most disabling conditions for both men and 
women.14 Given the substantial effect of headache and migraine on the quality of life 
of the sufferer and the significant disruption to work, family and social duties16-18 it is 
imperative that all effective headache and migraine treatments be explored and 
researched. 
 
Conventional medical intervention for headache and migraine often involves 
pharmacological treatment. Acetaminophen (paracetamol), acetylsalicylic acid 
(aspirin), dipyrone, derivatives of ergot fungus, chlorpromazine, triptans 
(Imitrex/Imigran et al.), and non-steroidal anti-inflammatories are the most 
commonly prescribed drugs for the acute treatment of headache and migraine.19 
Tricylic anti-depressants, beta-blockers and anti-epilepsy drugs are the most 
commonly prescribed and best evidence based classes of pharmacologic preventative 
interventions for episodic migraine.20 Despite many patients reporting benefits from 
these drug treatments, the pharmacological interventions are not without their 
limitations or side-effects. For instance, amitriptyline, one of the most widely used 
preventive antimigraine agents, has side-effects ranging from drowsiness, dry mouth, 
constipation and weight gain to the possibility of precipitating cardiac arrhythmias, 
seizures or exacerbating closed angle glaucoma.19 In addition, headache and 
migraine are often long term with relapses and remissions that create continuing 
distress and disruption to patients’ daily lives.16 
 
The treatment of headache and migraine is one area of health care where CAM 
treatment shows some promise.21-28 Nevertheless, the benefits and risks of CAM in 
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treating and managing headache and migraine disorders remain contested and a 
recent systematic assessment of the evidence base of CAM treatment for primary 
headache found that the overall quality of research of CAM approaches still lags 
behind studies of conventional medical approaches to primary headache.29 
 
Results from large cohort/population studies suggest that CAM use is common 
among headache and migraine patients. For instance, a United States (US) study on 
symptoms and conditions among CAM users in a large military cohort (n=86,131) 
suggested that about 10% of the respondents reported the problem of migraine 
headache and the study suggested this condition is more likely to be reported by 
CAM users than by people not using CAM.30 Analysis of the US National Health 
Interview Survey (n=31,044) also identified headache as one of the most common 
health problems experienced by CAM users.31 While these studies highlight a 
relationship between CAM use and headache disorders, they provided little 
information on the patterns of and motivations for CAM use among people with 
headache and migraine. 
 
Although evidence of CAM use for headache and migraine is emerging, there has 
been no review or synthesis of CAM user characteristics, perceptions or motivations 
amongst headache and migraine sufferers. Such a review is essential in order to 
provide important insights for health practitioners and policymakers with regards to 
the safety and continuity of care for patients – an issue pronounced by the fact that 
CAM users appear not to disclose such use to their conventional doctors, Previous 
studies reveal that a lack of GP interest in their patients’ use of CAM or the patients’ 
perception that CAM use is not an important issue that should be raised with their 
doctor are the two major factors contributing to nondisclosure of CAM.32-34 In 
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response, this paper provides the first synopsis and evaluation of the research 
findings on CAM use amongst patients with headache and migraine as identified 
from recent international empirical literature. Specifically, this paper aims to: 1) 
identify the relevant studies that examine the use of CAM among people with 
headaches; 2) analyse the quality of these studies; and 3) summarise the key findings 
from these studies using theme-based analysis. 
 
 
Methods 
Design 
The aim of the review is to examine the current prevalence, pattern and details of 
CAM use among people with headache and migraine. A comprehensive search of the 
literature between 2000 and 2011 was undertaken in line with the exponential 
growth in CAM use and growing research attention upon this topic over the past 
decade. The CINAHL, MEDLINE, Health Source and AMED databases were 
searched, using the following key terms and phrases: complementary 
medicine/therapy, alternative medicine/therapy, natural medicine/therapy, 
holistic medicine/therapy, headache, primary headache, migraine, cephalalgia, 
cephalgia, cranial pain and hemicrania. The CINAHL, MEDLINE and Health 
Source are three of the most popular, comprehensive databases for health and 
medicine scholarship. The AMED database was also chosen as an authoritative 
resource on allied health and complementary medicine scholarship.  The database 
search was confined to peer-reviewed articles published in English. 
 
To ensure all relevant international literature was identified, the authors also 
conducted hand searches in prominent headache and migraine journals including 
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Headache, Cephalalgia and Journal of Headache and Pain. Relevant works were 
also identified by examining bibliographies of publications.  
 
The search results were imported into Endnote,35 a bibliographic management 
system software program, with all duplicated items removed. The remaining titles 
and their abstracts were screened and assessed independently by two authors who 
employed the following criteria to identify relevant studies for inclusion in the 
review: Peer-reviewed, research-based papers reporting new empirical findings 
focusing upon either CAM use among people with primary headache or migraine, or 
CAM use amongst a broader population or general population where CAM use 
among headache and/or migraine patients was clearly identifiable and extractable. 
 
Those papers identified as individual case reports or CAM clinical trials were 
excluded from the review. In those circumstances where the abstract was deemed to 
not provide sufficient information, the full article was retrieved and examined prior 
to a final decision regarding inclusion or exclusion status. 
 
Search Outcomes 
The initial search identified 565 papers and a total of fourteen articles met the 
selection criteria. Two of these fourteen articles36 37 were subsequently eliminated 
due to  reporting the findings of surveys which were already covered elsewhere.38 39 
As a result, a total of twelve papers were included in this review. Figure 1 reports the 
literature search process and Table 1 summarizes the basic details of the included 
papers. 
 
Figure 1: Flowchart of Literature Search Process 
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Selection 
14 papers identified and 12 included in this review 
Filter 
Papers discarded for not meeting the selection criteria by title/abstract (n=555) 
Data Cleaning 
565 papers left after duplicates removed 
Supplment Search 
Hand and bibliography search (n=36) 
Search Hits 
CINAHL, MEDLINE, Health Source  and AMED (n=841) 
Primary Search 
(CAM) AND (headache, migraine, cephalalgia, cephalgia, cranial pain, hemicrania) 
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Table 1: Research-based studies on the use of complementary and alternative medicine for headache and migraine, 2000 - 2011 
Author/Country Design/Sampling Use Rate Popular Therapies Used Predictors of Use Special 
Remark 
Eisenberg et al.,
40
 
USA 
Survey of adults who 
saw a medical doctor 
and used CAM 
therapies 
National representative 
sample, n=831 
 
N.A. N.A. N.A. Study on 
the 
general 
populatio
n 
Gaul et al.,
38
 
Austria and 
Germany 
 
Survey of patients of 7 
tertiary headache 
centres 
Convenience sample, 
n=432 
81.7% used at least 1 CAM 
(life time use) for 
headache therapy 
71.1% used CAM in 
addition to conventional 
treatment for headache 
Median CAM therapies 
used for headache = 3.9 
during the course of 
disease  
Acupuncture (58%)  
Massage (46%)  
Relaxation techniques (42%) 
Homeopathy (23%) 
A higher number of 
headache days* 
Longer duration of 
headache treatment* 
Higher personal costs* 
Use of CAM for other 
diseases* 
Study on 
people 
with  
headach
e and 
migraine 
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Mean duration of CAM use 
for headache = 7.2 yrs  
 
Kazak et al.,
41
 
Switzerland 
Survey of outpatients of 
a headache and pain 
clinic 
Convenience sample, 
n=1,625 
 
29.8% reported use of CAM 
treatments before and 
after referral to the clinic 
Acupuncture (69.8%) 
Homeopathy (24.8%) 
N.A. Study on 
people 
with  
headach
e and 
migraine 
Lambert et al.,
42
 
UK 
 
Survey of patients 
attending an 
outpatient headache 
clinic 
Convenience sample, 
n=92 
32% used a median of 3 
CAM therapies for 
headache (life time use) 
46% used CAM for 
headache had also used 
it for other conditions 
(life time use) 
 
Massage (15%) 
Acupuncture (13%) 
Herbal medicine (12%) 
Exercise (11%) 
Vitamins/Supplements (10%) 
 
Headache Impact Test 
(HIT-6) score in the 
range of 42-60 and 
61-78 
 
Study on 
people 
with  
headach
e and 
migraine 
Metcalfe et al.,
43
 
Canada 
A community health 
survey of people 
aged ≥12 
National representative 
19.0% of people with 
migraine visited a CAM 
practitioner (in last 12 
months) 
People with migraine had 
significantly higher odds in using 
chiropractic service (OR=1.48) 
and massage therapist 
Migraine remained 
significant predictors 
(OR=1.42) of CAM 
use after controlling 
Study on 
the 
general 
populatio
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sample (n=400,055) People with migraine had a 
significantly higher odds 
of using CAM (OR=1.78) 
 
(OR=1.13) than the general 
population 
 
for demographic 
factors 
n 
Rossi et al.,
44
 
Italy 
 
 
 
 
 
 
 
 
 
 
 
Interview of patients 16-
65 yrs of a headache 
clinic with different 
migraine subtypes 
Convenience sample, 
n=481 
31% - used for migraine (in 
the past) 
17% - used for migraine (in 
last 12 months) 
69% - never use for 
migraine 
89% CAM users - used 
specifically for headache 
Median CAM therapies 
used for migraine = 1 
 
Acupuncture (27%) 
Homeopathy (22%) 
Massage (10%) 
Chiropractic (9%) 
 
A diagnosis of 
medication overuse + 
migraine without aura 
and chronic migraine 
Higher number of 
specialists consults 
Higher number of 
conventional general 
practitioner (GP) 
consults 
Co-morbid psychiatric 
disorders 
Higher annual 
household income 
Headache either 
misdiagnosed or not 
diagnosed 
Study on 
people 
with  
headach
e and 
migraine 
12 
 
 
Rossi et al.,
45
 
Italy 
Interview of patients 18-
65 yrs of a headache 
clinic suffering from 
chronic tension-type 
headaches (CTTH) 
Convenience sample, 
n=110 
40% - used for CTTH (in 
the past) 
23% - used for CTTH (in 
last 12 months) 
60% - never used for CTTH 
 
Chiropractic (22%) 
 Acupuncture (18%) 
 Massage (18%) 
 Homeopathy (8%) 
 
Higher number of 
lifetime conventional 
GP consults 
Co-morbid psychiatric 
disorders 
Higher annual 
household income 
Had never used 
pharmacological 
preventative therapy 
 
Study on 
people 
with  
headach
e and 
migraine 
13 
 
Rossi et al.,
46
 
Italy 
Interview of patients 18-
65 yrs of a headache 
clinic suffering from 
cluster headaches 
(CH) 
Convenience sample, 
n=100 
 
29% - used for CH (in the 
past)  
10% - used for CH (in last 
12 months) 
71% - never used for CH 
  
 
Acupuncture (30%) 
Homeopathy (14%) 
Acupressure (12%) 
Chiropractic (12%) 
Therapeutic touch (10%) 
 
Higher number of 
lifetime conventional 
GP consults 
Higher number of cluster 
headache per year 
 
 
Study on 
people 
with  
headach
e and 
migraine 
Soon et al.,
47
 
Singapore 
Surveys at baseline and 
3 months interval of 
patients of a 
specialist headache 
clinic 
Convenience sample, 
n=38 
 
34% reported use after 
consult with GP  
18% reported use after 
consult with specialist 
 
 
31% - traditional medicine (the most 
widely used therapies at 
baseline) 
11% - acupuncture (the most widely 
used therapies at 3 months 
interval) 
 
N.A. Study on 
people 
with  
headach
e and 
migraine 
von Peter et al.,
48
 
USA 
 
 
 
Interview of patients 18 
yrs and older with 
headache syndromes 
attending a head and 
neck pain clinic 
84% used 1 treatments for 
headache, with a mean 
amount of 32 
modalities used per 
Massage (42%) 
Exercise (30%) 
Acupuncture (19%) 
Biofeedback (15%) 
Chiropractic (15%) 
N.A. 
 
 
 
 
Study on 
people 
with  
headach
e and 
14 
 
 
 
Convenience sample, 
n=73 
patient (life time use) 
A mean knowledge of 79 
treatments per patient 
 
Herbs (15%) 
Vitamins/Supplements (14%) 
Therapeutic touch (10%) 
 
 
 
 
migraine 
Vukovic et al.,
49
 
Croatia 
Survey of adults 18 yrs 
old 
Convenience sample, 
n=616 115 with 
migraine (M) 
327 with tension-type 
headache (TTH) 
174 with probable 
migraine (PM) and 
TTH 
 
27% of M and 27% of TTH 
and 28% of PM patients 
used CAM (life time use) 
 
For M patients: 
Physical therapy (10%) 
Acupuncture (9%) 
Yoga, meditation (7%) 
 
For TTH patients: 
Physical therapy (12%) 
Chiropractics (4%) 
Acupuncture/Yoga, meditation (3%) 
 
For PM patients: 
Physical therapy (10%) 
Chiropractics (7%) 
Acupuncture (5%) 
 
N.A. Study on 
the 
general 
populatio
n 
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* Predictors for a higher number of used CAM treatments
Wells et al.,
39
 
USA 
 
Secondary analysis of a 
national health 
survey 
Representative sample, 
n = 23,393 
50% of adults with 
migraines or severe 
headaches used at least 
1 CAM (in last 12 
months), compared with 
34% of those without 
migraines or severe 
headaches; adjusted 
odds ratio = 1.29 with 
95% CI 
Mind–body therapies (including 
deep breathing exercises, 
meditation, yoga, progressive 
relaxation, guided imagery) were 
used most frequently among 
adults with migraines or severe 
headaches (30%) 
Higher educational 
attainment, a history 
of anxiety, joint or low 
back pain, light or 
heavy alcohol use, 
and living in the 
western USA 
Study on 
people 
with  
headach
e and 
migraine 
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Quality Appraisal 
In order to appraise the quality of the papers identified for review, the authors 
employed a quality scoring system (Table 2) drawing upon quality assessment 
tools previously used for assessing prevalence studies on low-back pain50 and 
CAM use amongst cancer patients.51 52 The use of these established analytical 
tools allowed for systematic comparison and evaluation of the CAM surveys 
reviewed.  
 
Table 2: Description of quality scoring system for the CAM surveys reviewed 
Dimensions of Quality Assessment Points Awarded* 
Methodology:  
A. Representative sampling strategy 1 
B. Sample size >500 1 
C. Response rate >75% 1 
D. Low recall bias (prospective data collection or retrospective data 
collection within past 12 months) 
1 
Reporting of participants’ characteristics:  
E. Types of headache/migraine 1 
F. Age 1 
G. Ethnicity 1 
H. Indicator of socioeconomic status (e.g. income, education) 1 
Reporting of CAM use  
I. Definition of CAM or modalities provided to participants 1 
J. Participants can name CAM therapies/modalities used (open 
question) 
1 
K. Use of CAM modalities assessed 1 
* Maximum score: 11 points 
Source: Adopted from Fejer, et al.
50
 and Bishop, et al.
51 52
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Two authors assigned scores to the studies separately, the results were then 
compared and disagreements and differences resolved by discussion. Table 3 
reports the quality score of each individual study. 
 
Table 3: Quality score of studies on complementary and alternative medicine use 
among headache and migraine patients * 
Authors/Year 
Dimensions of Quality Assessment 
Total 
Score 
Methodology Reporting of Participants’ 
Characteristics 
Reporting of 
CAM Use 
Gaul et al. 
(2009) 
1 [C] 3 [E,F,H] 3 [I,J,K] 7 
Kozak et al. 
(2005) 
2 [B,C] 3 [E,F,H] 1 [I] 6 
Lambert et al. 
(2010) 
1 [C] 3 [F,G,H] 3 [I,J,K] 7 
Rossi et al. 
(2005) 
0 3 [E,F,H] 3 [I,J,K] 6 
Rossi et al. 
(2006) 
0 3 [E,F,H] 3 [I,J,K] 6 
Rossi et al. 
(2008) 
0 3 [E,F,H] 3 [I,J,K] 6 
von Peter et al. 
(2002) 
0 4 [E,F,G,H] 2 [I,K] 6 
Wells et al. 
(2011) 
3 [A,B,D] 3 [F,G,H] 2 [I,K] 8 
* Eisenberg et al. 2001, Metcalfe et al. 2010, Soon et al. 2005 and Vukovic et al. 2010 do not 
focus solely upon CAM use for headache and migraine and as such the criteria ‘reporting of 
CAM use’ does not apply to these four studies and they were not assessed via the quality 
scoring system above.  
18 
 
 
 
Results 
The context and findings of the twelve papers were extracted, grouped and 
summarized using an integrative review approach.53 54 The data extracted 
were synthesized using the following themes: the prevalence of CAM use, user 
profile and predictors of use, motivation and perception of CAM use, and 
referral and disclosure of CAM use. 
 
The Prevalence of CAM Use 
The twelve papers selected for review reported a wide range of prevalence 
rates for CAM use among people with headache and migraine (refer to Table 
1). For instance, an analysis of national health survey data identified 50% of 
US adults with migraines or severe headaches as using at least one CAM over 
the past 12 month period.39 A similar analysis in Canada discovered that 19% 
of people with migraine visited a CAM practitioner in the last 12 months.43 A 
large cross-sectional cohort study among patients of tertiary headache centers 
in Austria and Germany found that 82% of the respondents had used CAM at 
some stage in their lifetime.38 Three studies conducted in Italy on patients 
with different types of headache disorders reported CAM use rates of 31% 
(amongst patients with migraine), 40% (amongst patients with chronic 
tension-type headaches) and 29% (amongst patients with cluster 
headaches).44-46 Meanwhile, another survey of adults in Croatia identified 
28% of respondents with headache disorders had used CAM (lifetime 
prevalence).49 Despite these variations in findings, the studies do indicate 
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relatively substantial prevalence of CAM use among people suffering from 
headache and migraine. 
 
There are several factors that may account for the differences in reported 
prevalence of CAM use. First of all, the differences may reflect variations in 
study or sample design with different studies targeting different populations 
or types of headache/migraine patients. For instance, patients in the general 
population may be different from patients presenting in headache specific 
clinics. In addition, studies have adopted different definitions of CAM which 
may also contribute to the differences in reported prevalence rates. For 
example, Rossi et al.44: 493 defined CAM as  ‘a wide range of pharmaceutical-
type and non-pharmacological therapies that do not, on the whole, fall within 
the sphere of conventional medicine’. In contrast, Lambert et al.42: 129 adopt a 
definition of CAM in their study that was ‘essentially respondent-defined’ and 
Metcalfe et al.,43 confined their analysis of CAM use to visits to CAM 
practitioners. Finally, the variation in ways of measuring CAM use (e.g. 
lifetime use or use in the past year) is another factor that renders the 
interpretation and comparison of prevalence estimates between studies of a 
particular challenge.  
 
Acupuncture, massage, chiropractic and homeopathy were the most common 
therapies reported as used by those suffering from headache and migraine in 
the studies reviewed. The findings of a large national representative survey 
suggested that mind-body therapies such as meditation, breathing exercise 
and yoga were the most common CAM used by US respondents with 
migraines or severe headaches.39 There is evidence that a majority of CAM 
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users seek CAM concurrent with (ranged from 7% to 30%) or following 
(ranged from 64% to 93%) a GP visit.42 44-46 In contrast, only a small 
proportion of respondents (ranging from 5% to 19%) used CAM before they 
visited a doctor.42 44-46. Lambert et al.42 also found that 80% of their study 
respondents did not relinquish their use of prescribed medications while 
consuming CAM. Together these results suggest that CAM is likely used as a 
complementary (alongside) rather than an alternative treatment (as a 
replacement) to conventional medicine among people with headache and 
migraine. 
 
CAM User Profile and Predictors of CAM Use 
The socio-demographic characteristics of headache and migraine sufferers 
who use CAM are similar to the profile of CAM users identified in the general 
population.9 12 Specifically, people with headache and migraine who use CAM 
are more likely to be female,38 39 42 44-48 be married,44-46 48 have a higher 
education level,38 39 42 44-46 48 report a higher annual income38 39 44-46 and be  
full-time employed.42 44-47 
 
 Research evidence indicates that the seriousness of headache conditions (in 
terms of number of headache days, duration of headache treatment or 
frequency of GP/specialist consulted) is an important factor that determines 
CAM consumption; people with more severe headache conditions are more 
likely to use CAM.38 43-46 Lambert et al.42 also found that a Headache Impact 
Test score − a widely used tool to measure the impact of headaches on a 
person’s ability to function on the job, at home, at school and in social 
situations − is of significance as a predictor of CAM use. In addition, analysis 
21 
 
of data from the 2007 National Health Interview Survey indicates that other 
health conditions or lifestyle characteristics such as a history of anxiety, joint 
or low back pain and alcohol use are independently associated with higher 
CAM use among patients with migraines or severe headaches.39 
 
Motivations for and Perceptions of CAM Use 
Table 4 summarises the findings regarding motivations and perceptions of 
CAM use from the twelve studies selected for review. Wells et al.39 identified 
that headache and migraine patients who employed CAM perceived 
conventional treatment as ineffective more often than those who did not use 
CAM and a national representative survey in the US revealed that 39% of 
those people who consulted a doctor and used CAM considered CAM as more 
effective than conventional medicine in treating headache.41 However, 
findings from other studies indicate that only a small portion of headache and 
migraine patients sought CAM in response to a bad experience or 
dissatisfaction with their conventional treatment.38 42 44-46  
 
The most common reasons for CAM use as identified by Gaul et al.38 were ‘to 
leave nothing undone’ (64%) and ‘to be active against the disease’ (56%). This 
study also found that other considerations like ‘anxiety of side-effects [of 
conventional treatments]’ (20%) and ‘request for a therapy without side 
effects’ (31%) were also important in headache and migraine patients seeking 
CAM. Lambert et al.42 found that 48% of their respondents chose to use CAM 
‘as a last resort’. The three Italian studies by Rossi et al.44-46 identified a belief 
amongst patients that CAM was ‘potentially beneficial for headache’ (about 
45%) or CAM was ‘safer and [with] less side-effects [than conventional 
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treatments]’ (about 27%) as major reasons for CAM use.  In contrast, the 
analysis of the US national health survey data reveals that while nearly half of 
adults with migraines or severe headaches use CAM, only about 5% of them 
use CAM to specifically treat their headache/migraine symptoms. Instead, the 
main reasons of using CAM as reported in this study were ‘general 
wellness/disease prevention’ and ‘to improve/enhance energy’.39 
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Table 4: Motivation, perception and referral/disclosure of CAM use for headache and migraine 
Author/Country Motivation for Use Perception of Use Referral/Disclosure 
Eisenberg et al.,
40
 
USA 
N.A. 39% - CAM to be more helpful than 
conventional medicine for treatment of 
headache 
 
N.A. 
Gaul et al.,
38
 Austria 
and Germany 
 
64% - ‘to leave nothing undone’  
56%- ‘to be active against the disease’ 
40% - ‘not to take a permanent 
medication’ 
39% - ‘advice from another person’ 
34% - ‘dissatisfaction from conventional 
treatment’ 
31% - ‘request for a therapy without side-
effects’ 
20% - ‘anxiety of side-effects’ 
N.A. NA 
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9% - ‘bad experience with regular 
treatments’ 
8% - other 
 
Lambert et al.,
42
 UK 
 
48% - as a last resort 
21% - believed it was effective 
17% - unhappy with conventional 
treatment 
14% - GP recommendation 
 
60% - found therapy greatly reduced/reduced 
headache 
40% - found therapy had no effect on 
headache 
58% - satisfied/very satisfied with therapy 
35% - dissatisfied/very dissatisfied with 
therapy 
0% - made headache worse 
Referral : 
72% - Friend/relative 
16% - GP  
8% - Nurse 
4% - Self-recommendation 
 
Disclosure: 
58% - informed GP / nurse 
42% - did not inform GP /nurse 
 
Rossi et al.,
44
 Italy 
 
 
 
48% - potential benefit 
27% - safer and less side-effects 
11% - GP recommendation 
10% - proven beneficial for headache 
40% - effective 
57% - ineffective 
4% - made condition worse 
 
Referral: 
53% - friends/relatives 
34% - Doctor 
13% - Self-recommendation 
25 
 
 
 
 
 
5% - dissatisfied with conventional 
treatment 
  
Disclosure : 
39% - informed GP  
61% - did not inform GP  
 
Rossi et al.,
45
 Italy 45% - potential benefit 
27% - safer and less side-effects 
18% - GP recommendation 
9% - dissatisfied with conventional 
treatment  
41% - effective 
59% - ineffective 
 
Referral: 
41% - friends/relatives 
34% - GP  
25% - Self-recommendation 
 
Disclosure: 
40% - disclosed to GP  
60% - did not disclose to GP  
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Rossi et al.,
46
 Italy 45% - potential benefit 
28% - safer and less side-effects 
14% - GP recommendation 
10% - holistic approach to health 
5% - dissatisfied with conventional 
treatment  
 
 
36% - effective or quite effective 
58% - ineffective 
6% - made condition worse 
Referral: 
54% - friends/relatives 
26% - GP  
20% - Self-recommendation 
 
Disclosure: 
38% - disclosed to GP  
62% - did not disclose to GP  
 
Soon et al.,
47
 
Singapore 
N.A. N.A. 5% reported informing GP about the 
use 
11% reported informing the specialist 
about the use 
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von Peter et al.,
48
 USA 
 
 
 
 
N.A. 60% - considered therapies used to have a 
benefit 
The highest percentage of patients believed in 
massage (28/8%), acupuncture (28.7%) 
and meditation (16.4%) for the relief of 
headache 
 
N.A. 
Vukovic et al.,
49
 
Croatia 
N.A. 39% of M, 60% of TTH and 41% of PM 
patients satisfied with CAM  
 
N.A. 
Wells et al.,
39
 USA 
 
Main reasons for CAM use: 
- general wellness/disease prevention   
- family/friends recommendation 
- to improve/enhance energy 
Only 5% adults with migraines or severe 
headaches used CAM to specifically 
treat their headache symptoms 
Adults with migraines/severe headaches 
N.A. Disclosure: 
43% discussed CAM use with 
healthcare provider 
Adults with migraines/severe 
headaches had a higher 
disclosure rate (47%) than those 
without (42%) 
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used CAM more often than those 
without because: 
-  their provider recommended it (31% 
vs. 23%) 
- conventional treatment was 
ineffective (21% vs. 13%) 
- conventional treatment was too 
expensive (11% vs. 5%) 
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Previous study findings indicate that perceptions of CAM effectiveness are 
mixed among headache and migraine patients who are CAM users. Lambert et 
al.42 explain that 60% of respondents report CAM as reducing/greatly 
reducing their headache and 58% were satisfied with the therapy used. Von 
Peter et al.48 also found that 60% of the headache patient population 
interviewed perceived CAM as of potential benefit for the treatment and relief 
of headache. 
 
However, the three surveys conducted by Rossi et al.44-46 reveal that over half 
of respondents (ranging from 57% to 59%) experienced CAM as ineffective in 
the treatment of their headache disorders and this was particularly the case 
among those with migraine (73.1% reporting CAM as being ineffective).44 In 
addition, about 5% of respondents in two of these Italian studies reported 
CAM treatment as resulting in a deterioration of their condition.44 46 Finally, 
Vukovic et al.49 report that satisfaction with CAM varied among patients 
suffering from different kinds of headache conditions, with 39% of patients 
with migraine, 60% of patients with tension-type headache, and 41% of 
patients with probable migraine and tension-type headache reporting 
satisfaction with their CAM treatment. 
 
Referral to and Disclosure of CAM Use 
A review of the research literature identifies three key sources utilised by 
people with headache and migraine to gain information about CAM. A 
substantial proportion of headache and migraine patients using CAM (ranging 
from 41% to 72%) obtain information about CAM from their acquaintances or 
relatives.42 44-46 The patients’ doctor or nurse was the second common referral 
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source through which headache and migraine patients became familiar with 
CAM (ranging from 16% to 34%) and a relatively small proportion of headache 
and migraine patients (ranging from 4% to 20%) relied solely upon their own 
judgement with regards to using these treatments.42 44-46 
 
In line with findings from studies of general CAM users,32 headache and 
migraine patients utilising CAM do not commonly inform their doctor or 
nurse about such CAM use. Wells et al.39 discovered that although CAM users 
with migraine or headache had a higher disclosure rate than those without 
migraine or headache, less than half (47%) discuss their CAM use with their 
conventional healthcare provider(s). The three surveys conducted in Italy by 
Rossi et al.44-46 identify over 60% of respondents as failing to disclose their 
CAM use to their conventional doctor. Meanwhile, Soon et al.47 reveal that 
only 16% of headache and migraine patients in Singapore using CAM 
informed their doctor or specialist about such use.  
 
In contrast, Lambert et al.,42 examining headache and migraine patients in 
the UK, report 58% of their respondents as disclosing CAM use to their doctor 
or nurse. However, the same survey also discovered that 80% of respondents 
report their doctor or nurse as never enquiring or initiating discussion with 
them about CAM use. Rossi et al.44 also questioned their respondents about 
their reasons for failing to inform conventional doctors about their CAM use. 
In response, 37% of the migraine patients reported that their doctors never 
ask for this information and 50% of them considered CAM use as a matter 
either ‘not important for the doctor to know’ or ‘none of the doctor’s business’. 
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Discussion  
This paper provides the first critical, comprehensive review of the evidence 
base of CAM use and users among people suffering from headache and 
migraine. The use of CAM among patients with headache and migraine is an 
issue that has increasingly attracted the attention of practitioners and 
researchers over the past decade28 55 56 as reflected by the review findings with 
the bulk of empirical studies (ten out of the twelve studies identified over the 
last 11 years) having been published since 2005.   
 
Although the evidence base focused upon CAM use among headache and 
migraine patients has begun to emerge, the ability of this review to generalise 
from studies or compare findings across studies remains difficult with 
variations in research design and the definition of CAM employed between 
studies of particular challenge. This is a problem that also plagues the 
assessment of clinical outcomes of CAM therapies on treating primary 
headache.29 In addition, this review is confined to English language 
publications and the omission of non-English materials may introduce some 
bias. 
 
Despite these limitations, the evidence identified and examined in this review 
does, nevertheless, suggest a substantial level of CAM use among people with 
headache and migraine. There is also evidence of many headache and 
migraine sufferers using CAM concurrent to their conventional medicine use 
(as a complement rather than alternative), a finding consistent with survey 
results of CAM use in the broader general population.9 57 
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The frequent use of a range of CAM amongst people with headache and 
migraine warrants further investigation. There is evidence that many people 
use CAM as a follow-up treatment or last resort in an attempt to relieve their 
headache and migraine symptoms. In contrast, recent findings of a large 
national health survey indicate that only a small proportion of people with 
migraines and severe headaches use CAM specifically for the treatment of 
their headache conditions.39 The co-existence of a high CAM usage with the 
fact that a substantial proportion of users consider CAM ineffective in treating 
their headache symptoms is also interesting.44-46 In short, the role of CAM in 
treating headache and migraine symptoms or helping patients to cope with 
their distress in their everyday lives remains unclear. There is a need for 
further in-depth qualitative studies on the motivations, experiences and 
perceptions of CAM use amongst headache and migraine sufferers. 
 
The prevalence of CAM use amongst headache and migraine patients also has 
implications for conventional health care providers. Since the prevalence rate 
of CAM is high amongst headache and migraine patients and a substantial 
percentage of these patients appear to not disclose their CAM use to 
conventional practitioners, healthcare professionals should be prepared to 
enquire and discuss with their patients about possible CAM use. Relevant 
healthcare providers should also pay attention to the possible adverse effects 
of CAM or interactions between CAM and conventional medical treatments 
amongst headache and migraine patients. This is important given a very small 
minority of headache and migraine patients who utilize CAM report 
deterioration in their condition.44 46 
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In light of this review it is possible to identify areas for future research 
attention pertaining to headache and migraine patients and CAM use. As the 
quality scores reported in Table 3 indicate, the studies examining this topic to 
date have been methodologically weak. Only two of the studies attracted a 
sample size over 500 with only one of them employing a nationally 
representative sample. As such, there is a pressing need for rigorous studies 
examining this important field of CAM use and user research, employing 
mixed method designs and utilizing large and/or representative national 
samples where possible.  
 
Meanwhile, given all previous research has utilized cross-sectional study 
design, there is also a need for longitudinal studies to examine changes in 
CAM use in accordance with changes in conventional treatments and severity 
of the headache disorders and throughout different stages of the headache and 
migraine patient’s illness and treatment journey.  
 
While remaining mindful of cultural contexts and variations in CAM, 
researchers are also recommended to adopt a common taxonomy or 
classification of CAM practices/exposures in self-reported descriptive surveys 
of CAM use for headache and migraine where possible.58 This will help 
address challenges resulting from rapid developments regarding evidence and 
institutional approvals. For example Petasites hybridus or butterbur root was 
recently found to have Level A evidence for proof of benefit in episodic 
migraine by the Quality Standards Subcommittee of the American Academy of 
Neurology and the American Headache Society.20 As the evidence-base 
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demonstrates, the use and satisfaction with CAM varies among patients 
suffering from different kinds of headache and migraine.49 Future research 
will benefit from differentiating and/or targeting patients suffering from 
different and specific types or severities of headache and migraine. Together, 
these design features will strengthen the evidence base of CAM use on this 
topic and provide a much better picture of CAM consumption for the 
treatment of headache and migraine. 
 
 
Conclusion 
The use of CAM appears to constitute a treatment option considered and 
employed by a substantial proportion of patients suffering from headache and 
migraine. This review has provided essential insights into the prevalence and 
details of CAM use and related issues amongst headache and migraine 
patients with implications for practitioners (both conventional and CAM) and 
health policy-makers. It is recommended that further research utilizing both 
quantitative and qualitative methods be undertaken to address a number of 
important issues still requiring attention and essential to helping a range of 
stakeholders provide effective, safe and responsive care and services for those 
suffering from headache and migraine.  
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